Bicarbonate

Bicarbonate

SCHEMBL18280952

O=C(O)O.[H+].[Zn+2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL7523400 0.94
Bicarbonate SCHEMBL23174995 0.93
Bicarbonate SCHEMBL21618365 0.93
Bicarbonate SCHEMBL578795 0.93
Bicarbonate SCHEMBL21831917 0.86
Bicarbonate SCHEMBL23163235 0.86
Bicarbonate SCHEMBL23044866 0.86
Bicarbonate SCHEMBL21815794 0.86
Bicarbonate SCHEMBL21526741 0.86
Bicarbonate SCHEMBL23163232 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027072-A1 COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS INC (US) 2026-01-29 US disclosed
US-20220331355-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA LPOXY THERAPEUTICS, INC. 2022-10-20 US disclosed
US-11311573-B2 Pharmaceutical preparations and methods to manage weight and to modulate the gut microbiota XENO BIOSCIENCES INC. (US) 2022-04-26 US disclosed
EP-3915552-A1 COMPOSITIONS FOR USE IN MODULATING THE GUT MICROBIOTA AND MANAGING WEIGHT Xeno Biosciences Inc. (US) 2021-12-01 EP disclosed
US-11179357-B2 Methods and compositions to modulate the gut microbiota and to manage weight XENO BIOSCIENCES INC. (US) 2021-11-23 US disclosed
US-11179356-B2 Methods and compositions to modulate the gut microbiota and to manage weight XENO BIOSCIENCES INC. (US) 2021-11-23 US disclosed
US-20210177784-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS, INC. 2021-06-17 US disclosed
US-20210169829-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS, INC. 2021-06-10 US disclosed
US-20210161839-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS, INC. 2021-06-03 US disclosed
US-10945974-B2 Methods and compositions to modulate the gut microbiota and to manage weight XENO BIOSCIENCES INC. (US) 2021-03-16 US disclosed
US-20200078397-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA XENO BIOSCIENCES INC. (US) 2020-03-12 US disclosed
EP-3548008-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA Xeno Biosciences Inc. (US) 2019-10-09 EP disclosed
WO-2018102469-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA XENO BIOSCIENCES INC. (US) 2018-06-07 WO disclosed
US-20180147167-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT XENO BIOSCIENCES INC. (US) 2018-05-31 US disclosed
EP-3302703-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT Xeno Biosciences Inc. (US) 2018-04-11 EP disclosed
WO-2016196440-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT XENO BIOSCIENCES INC. (US) 2016-12-08 WO disclosed